All In Biotech

Free tool

FAERS Monitor: Qnasl

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 202813 or its brand name (Qnasl, Beclomethasone Dipropionate). Reports on generic versions are filed under their own applications.

Reports

7,437

Serious

5,923

80% of reports

Hospitalization

2,226

Death reported

558

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea557
  • asthma369
  • headache354
  • vomiting349
  • nausea344
  • drug ineffective338
  • fatigue337
  • malaise318
  • diarrhoea314
  • cough306
  • pneumonia298
  • off label use251
  • dizziness249
  • wheezing222
  • pain220

Reports by year received

View as table
YearReports
2004206
2005233
2006167
2007230
2008278
2009151
2010146
2011221
2012399
2013273
2014207
2015234
2016291
2017158
2018182
2019217
2020236
2021319
2022690
2023691
2024743
2025725
2026440

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,722 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
wheezingSignal22210.69.31,924
asthmaSignal3699.38.42,717
coughSignal3063.12.8435
dyspnoeaSignal5572.82.6652
pneumoniaSignal2982.62.3297
vomitingSignal3492.11.9204
malaiseSignal3182.11.8174
headache3541.61.481
dizziness2491.41.230
diarrhoea3141.41.233
nausea3441.21.115
fatigue3371.21.114
pain2201.00.90
off label use2510.80.711
drug ineffective3380.70.737

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.